Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 12Esophageal Neoplasms 10Esophageal Squamous Cell Carcinoma 8Squamous Cell Carcinoma of Head and Neck 3Carcinoma, Squamous Cell 3Uterine Cervical Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Resectable Lung Non-Small Cell Carcinoma 1Recurrence 1Neoplasms 1Lymphoma 1Immunotherapy Esophagus Cancer 1Hypopharyngeal Neoplasms 1Hepatic Artery Infusion 1Head and Neck Neoplasms 1Central Nervous System Neoplasms 1Advanced Solid Tumor 1Advanced Non-squamous Non-Small-Cell Lung Cancer 1

Interventions

Cisplatin 29Magnetic Resonance Spectroscopy 16Specimen Handling 13pembrolizumab 11Radiotherapy, Intensity-Modulated 11Radiotherapy 11Cetuximab 11Paclitaxel 9Fluorouracil 9Docetaxel 9Surgical Procedures, Operative 8Platinum 81,2-diaminocyclohexaneplatinum II citrate 8Radiation 6Carboplatin 6Taxes 5toripalimab 4X-Rays 4Fluorodeoxyglucose F18 4Celecoxib 4Biopsy 4(225)Ac-DOTA-c(RGDyK) 4Chemoradiotherapy 3130-nm albumin-bound paclitaxel 3motexafin gadolinium 2ipatasertib 2camrelizumab 2Surveys and Questionnaires 2Standard of Care 2Radiotherapy, Image-Guided 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hypopharyngeal Neoplasms × nedaplatin × Clear all
NCT05860335 2024-02-20

Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer

Chinese PLA General Hospital

Phase 2 Unknown
30 enrolled
Head & Neck

Hypopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡